Oliver Sexton

Oliver Sexton

Oliver Sexton joined Midven in April 2014 to manage the Rainbow Seed Fund’s synthetic biology investments.

Prior to joining Midven, Oliver managed commercialisation of bioengineering and medical technologies At Imperial Innovations and was on the board of oncology therapeutic Acublate Ltd. Earlier in his career he held commercial and partnering roles at Ark Therapeutics.

Oliver also managed a team of biotech buy-side analysts and worked at a pharma strategy consultancy.

Oliver has a BSc in Molecular Biology/Biotechnology and an MSc in Plant Science from Bristol University.

Position Investment Director

Telephone 0121 710 1990

“Turning world-leading research into profitable companies is no simple matter, but we are now at a point where many of those technologies are suitable for broad commercial application. Rainbow Seed Fund is providing not just capital, but the expertise and the networks to maximize the chances of success in existing markets and in the new markets that synthetic biology enables.”

Oliver Sexton

Associated Companies

Relevant News

Cytox Announces Participation In Insight Alzheimer’s Study

Participation will aid comparison of SNP genotyping with biomarker status Cytox Ltd, an innovative developer…

read more

Dow AgroSciences, Synthace Research Collaboration to Accelerate Product Development Using High Tech Tools

Synthace and Dow AgroSciences LLC, a wholly owned subsidiary of The Dow Chemical Company (NYSE:DOW), today…

read more

Desktop Genetics Ltd Raises £1.37 Million GBP ($2.15M USD) Funding

This latest round of investment will enable Desktop Genetics to commercialize its proprietary DESKGEN genome…

read more

Quethera Announces Seed Financing To Develop Gene Therapy Aimed At Preventing Blindness In Glaucoma Patients

Quethera, a gene therapy company developing a treatment for glaucoma that could prevent blindness, has…

read more

Case Studies

Case Study - Synthace

Synthace London-based Synthace provides next-generation software and processes to exponentially improve productivity in bioscience, enabling…

read more

Case Study - ZuvaSyntha Ltd

Summary: ZuvaSyntha is developing proprietary renewable manufacturing routes to industrial chemicals from low cost feedstocks…

read more

Blog

Today’s Academic Projects Are Becoming Tomorrow’s Billion Pound Companies

  When we talk about the tech revolution that is currently sweeping the industrialised world,…

read more

Other Team Members